Key Insights

Highlights

Treatment Research

2 treatments under study, led by Deepithelisation Of The Corneal Graft Support With Instillation Of Riboflavin

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03041883Not ApplicableRecruitingPrimary

Corneal Collagen Crosslinking to Increase the Resistance of the Support Graft of the KPro Type I Against Corneal Melting

Showing all 1 trials

Research Network

Common Treatments

  • Deepithelisation Of The Corneal Graft Support With Instillation Of Riboflavin1
  • Crosslinking With Riboflavin Of The Corneal Graftsupport1

Active Sponsors

  • Centre hospitalier de l'Université de Montréal (CHUM)1
  • Maisonneuve-Rosemont Hospital1

Top Investigators

Activity Timeline